Pharmacological treatment of Parkinson's disease

Postgrad Med J. 2000 Oct;76(900):602-10. doi: 10.1136/pmj.76.900.602.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Amantadine / therapeutic use
  • Antiparkinson Agents / classification
  • Antiparkinson Agents / therapeutic use*
  • Apomorphine / therapeutic use
  • Catechol O-Methyltransferase / therapeutic use
  • Diagnosis, Differential
  • Dopamine Agonists / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Levodopa / therapeutic use
  • Middle Aged
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Parkinson Disease / psychology

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Monoamine Oxidase Inhibitors
  • Levodopa
  • Amantadine
  • Catechol O-Methyltransferase
  • Apomorphine